INTELLIGENT BIO SOLUTIONS INC. Increase (Decrease) in Accounts Payable, Trade
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Increase (Decrease) in Accounts Payable, Trade of -$635.57 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2021-11-12
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts payable, trade for the quarter ending 2021-09-30 was -$635.57K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts payable, trade for the quarter ending 2021-06-30 was $102.05K, a 92.17% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts payable, trade for the quarter ending 2021-03-31 was $733.57K, a 554.47% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts payable, trade for the quarter ending 2020-12-31 was $259.39K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts payable, trade for fiscal 2021 was $782.97K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts payable, trade for fiscal 2020 was -$350.20K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$635.57K 10-Q · filed 2021-11-12 | -$533.52K derived: sum of 2 quarters · filed 2021-11-12 | $200.05K derived: sum of 3 quarters · filed 2021-11-12 | $459.44K derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | $102.05K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-16 | $835.62K derived: sum of 2 quarters · filed 2021-09-16 | $1.10M derived: sum of 3 quarters · filed 2021-09-16 | $782.97K 10-K · filed 2021-09-16 |
| 2021-03-31 | $733.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | $992.96K derived: sum of 2 quarters · filed 2021-05-13 | $680.92K 10-Q · filed 2021-05-13 | $734.03K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-12-31 | $259.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-12 | -$52.64K 10-Q · filed 2021-02-12 | $461.00 derived: sum of 3 quarters · filed 2021-11-12 | $112.55K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-09-30 | -$312.04K 10-Q · filed 2021-11-12 | -$258.93K derived: sum of 2 quarters · filed 2021-11-12 | -$146.85K derived: sum of 3 quarters · filed 2021-11-12 | |
| 2020-06-30 | $53.10K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-16 | $165.19K derived: sum of 2 quarters · filed 2021-09-16 | -$350.20K 10-K · filed 2021-09-16 | |
| 2020-03-31 | $112.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | -$403.31K 10-Q · filed 2021-05-13 | ||
| 2019-12-31 | -$515.39K 10-Q · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |